News | March 14, 2026
Co-Diagnostics bags key Japanese patent, bolstering global push for rapid PCR testing
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
The decision marks a pivotal moment for the Massachusetts-based biotech giant
The Japanese Patent Office has issued a favorable Appeal Decision granting a patent for the use of REQORSA Gene Therapy in combination with PD-L1 antibodies to treat cancer
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
Dr Adams’ lab recently uncovered a novel cellular detoxification pathway driving Cisplatin resistance in NSCLC
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
N17350 is the company’s first-in-class tumor-directed therapeutic, designed to harness the ELANE pathway
Subscribe To Our Newsletter & Stay Updated
